Abstract
The presentation of antigenic peptides by major histocompatibility complex (MHC) class I and class II molecules is crucial for activation of the adaptive immune system. The nucleotide-binding domain and leucine-rich repeat receptor family members CIITA and NLRC5 function as the major transcriptional activators of MHC class II and class I gene expression, respectively. Since the identification of NLRC5 as the master regulator of MHC class I and class-I-related genes, there have been major advances in understanding the function of NLRC5 in infectious diseases and cancer. Here, we discuss the biological significance and mechanism of NLRC5-dependent MHC class I expression.
| Original language | English |
|---|---|
| Pages (from-to) | 252-261 |
| Number of pages | 10 |
| Journal | Immunology |
| Volume | 162 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- cancer immune evasion
- class I transactivator
- major histocompatibility complex class I
- regulatory factor X
Fingerprint
Dive into the research topics of 'MHC class I transactivator NLRC5 in host immunity, cancer and beyond'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver